```json
{
"content": [
{
"type": "paragraph",
"content": "The electronystagmography testing ecosystem spans upstream technology development, midstream system integration, and downstream clinical deployment. Value is generated through the convergence of specialized hardware, diagnostic software, and healthcare infrastructure, enabling precise evaluation of vestibular disorders. The ecosystem relies on coordinated efforts across suppliers, integrators, and end users to ensure clinical efficacy and regulatory compliance."
},
{
"type": "list",
"items": [
{ "text": "Component Suppliers — supply sensors, amplifiers, and signal processing units for testing devices", "level": 1 },
{ "text": "Technology Providers — develop diagnostic software for eye movement analysis and data interpretation", "level": 1 },
{ "text": "Original Equipment Manufacturers (OEMs) — design and produce electronystagmography testing systems", "level": 1 },
{ "text": "System Integrators — assemble hardware-software solutions for clinical environments", "level": 1 },
{ "text": "Distributors — facilitate equipment and consumables delivery to healthcare facilities", "level": 1 },
{ "text": "Healthcare Providers — conduct tests in hospitals, clinics, and specialty centers", "level": 1 },
{ "text": "Regulatory Bodies — establish certification standards and approval processes for medical devices", "level": 1 }
]
},
{
"type": "paragraph",
"content": "Control points reside with regulators and technology providers, who shape adoption through approval pathways and innovation cycles. Dependency risks include component shortages and evolving compliance requirements. High switching costs for end users due to device-specific training and interoperability constraints reinforce partnerships between OEMs and integrators. Regional variations in healthcare infrastructure further influence ecosystem dynamics."
}
]
}
```
